This company listing is no longer active
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Radius Health 관리
관리 기준 확인 2/4
주요 정보
G. Martin
최고 경영자
US$3.5m
총 보상
| CEO 급여 비율 | 17.2% |
| CEO 임기 | 2.3yrs |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | less than a year |
| 이사회 평균 재임 기간 | 6.8yrs |
최근 관리 업데이트
Recent updates
Radius Recycling Stays In The Scrap Pile
Jul 16Radius Recycling: An Attractive, But Volatile, Play On A Cleaner Future
Jun 03Radius stock rises as elacestrant gets FDA priority review to treat breast cancer subtype
Aug 11Reevaluating Radius Health
Feb 24Radius Health EPS misses by $0.02, misses on revenue
May 07When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable?
Feb 23
Revisiting Radius Health
Feb 01Radius Health acquires global rights to RAD011 in Prader-Willi syndrome
Jan 06How Much Did Radius Health's(NASDAQ:RDUS) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 01
Radius Health on-track for record quarterly revenue for TYMLOS-SC
Dec 15CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$69m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$600k | -US$70m |
| Sep 30 2021 | n/a | n/a | -US$76m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$87m |
| Dec 31 2020 | US$12m | US$413k | -US$109m |
보상 대 시장: G.'s total compensation ($USD3.49M) is above average for companies of similar size in the US market ($USD2.61M).
보상과 수익: G.'s compensation has been consistent with company performance over the past year.
CEO
G. Martin (63 yo)
2.3yrs
테뉴어
US$3,493,881
보상
Mr. G. Kelly Martin has been Executive Chairman of Wren Therapeutics Ltd. since 2018. Mr. Martin serves as the Chief Executive Officer, President and Director at Radius Health, Inc. since April 28, 2020.H...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$3.49m | 데이터 없음 | |
| VP of Sales & Head of U.S. Sales Channels | less than a year | US$741.78k | 데이터 없음 | |
| Senior VP & Chief Business Officer | 2.2yrs | US$1.22m | 0.27% $ 1.3m | |
| Founder & Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Founder & Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Founder | no data | 데이터 없음 | 데이터 없음 | |
| Founder & Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| VP, CFO | less than a year | 데이터 없음 | 데이터 없음 | |
| Head of Corporate Finance | no data | 데이터 없음 | 데이터 없음 | |
| Head of Investor Relations | less than a year | 데이터 없음 | 데이터 없음 | |
| General Counsel | less than a year | 데이터 없음 | 데이터 없음 | |
| Head of Corporate & Business Development | less than a year | 데이터 없음 | 데이터 없음 |
0.8yrs
평균 재임 기간
61.5yo
평균 연령
경험이 풍부한 관리: RDUS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$3.49m | 데이터 없음 | |
| Founder & Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Founder & Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Founder | no data | 데이터 없음 | 데이터 없음 | |
| Founder & Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 6.7yrs | US$544.81k | 0.045% $ 215.1k | |
| Independent Director | 2yrs | US$534.84k | 0.012% $ 55.5k | |
| Independent Director | 7.8yrs | US$536.69k | 0.037% $ 178.7k | |
| Chairman of Scientific Advisory Board | 10.5yrs | US$30.00k | 데이터 없음 | |
| Independent Chairman | 9.3yrs | US$832.23k | 0.034% $ 163.1k | |
| Independent Director | 7yrs | US$556.41k | 0.045% $ 215.1k | |
| Member of Scientific Advisory Board | 3.8yrs | US$1.94m | 데이터 없음 |
6.8yrs
평균 재임 기간
68.5yo
평균 연령
경험이 풍부한 이사회: RDUS's board of directors are considered experienced (6.8 years average tenure).